title: HIV serosurveillance of newborns. A clinician's perspective on legislative, political, and ethical issues.
abstract: This article reviews the complex issues surrounding the anonymous HIV testing of newborns to monitor the prevalence of HIV infection in women of childbearing age. This serosurveillance of newborns has become a topic of legislative debate focusing on disclosure of currently anonymous results of HIV antibody tests of newborns, thus revealing the serostatus of the mother. This, in effect, would mandatorily test women without their consent. The discussion includes the following topics: (a) the historical demographics of incidence rates of AIDS, (b) current political and legislative issues raised by serosurveillance, (c) professional and ethical issues confronting health care providers, and (d) why HIV testing of newborns is a mandatory testing of all women of childbearing age. It is recommended that principles of patients right of self-determination be respected, that mandatory testing would be counterproductive and would disproportionately impact on minorities. The integration of education, counseling, and voluntary testing will result in the most effective way to get both women and children into the health care system.
authors.affiliation: Department of Psychiatry, North Shore University Hospital-Cornell University Medical Center, Manhasset, NY 11030, USA.
authors.forename: C
authors.initials: C
authors.lastname: Garrett
mesh_terms: D015492:AIDS Serodiagnosis / Q000331:legislation & jurisprudence*; D003219:Confidentiality / Q000331:legislation & jurisprudence*; D004992:Ethics, Medical; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D015528:HIV Seroprevalence / Q000639:trends*; D006801:Humans; D007231:Infant, Newborn; D007258:Informed Consent / Q000331:legislation & jurisprudence; D009518:New York / Q000453:epidemiology; D010358:Patient Participation / Q000331:legislation & jurisprudence; D011057:Politics; D011159:Population Surveillance; D011247:Pregnancy; D011295:Prenatal Care; D015215:Zidovudine / Q000008:administration & dosage
chemical_list: D015215:Zidovudine